Cytek Biosciences (CTKB) EBIT Growth (3y) (2023 - 2026)
Cytek Biosciences (CTKB) EBIT Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 129.08 Bn | 126.21 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 68.52 Bn | 67.07 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | 7.13% |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 75.54% |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.88 Bn | 1.98 Bn | -2.70% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.37 Bn | 21.25 Bn | 2.07 Bn | 34.83% |
| 10 | Cytek Biosciences | 565.66 Mn | 499.96 Mn | 21.25 Mn | -14.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.93% |
| Dec 31, 2025 | -309.35% |
| Sep 30, 2025 | -106.13% |
| Jun 30, 2025 | -128.46% |
| Mar 31, 2025 | -85.21% |
| Dec 31, 2024 | 31.37% |
| Sep 30, 2024 | -51.34% |
| Jun 30, 2024 | -61.82% |
| Mar 31, 2024 | -125.60% |
| Dec 31, 2023 | -26.36% |
| Sep 30, 2023 | -43.53% |
| Jun 30, 2023 | -247.24% |